Table 2.
Correlation analysis of SHR, ABG and HbA1c with established markers of PAH severity
| Variables | SHR | ABG | HbA1c | |||
|---|---|---|---|---|---|---|
| Coefficient (r) | P value | Coefficient (r) | P value | Coefficient (r) | P value | |
| WHO-FC | 0.196 | < 0.001 | 0.267 | < 0.001 | 0.150 | < 0.001 |
| 6MWD | − 0.187 | < 0.001 | − 0.287 | < 0.001 | − 0.212 | < 0.001 |
| ln (NT-proBNP) | 0.181 | < 0.001 | 0.384 | < 0.001 | 0.339 | < 0.001 |
| Pericardial effusion | 0.094 | 0.019 | 0.220 | < 0.001 | 0.220 | < 0.001 |
| RAP | 0.067 | 0.097 | 0.259 | < 0.001 | 0.259 | < 0.001 |
| mPAP | 0.022 | 0.589 | 0.053 | 0.188 | 0.030 | 0.459 |
| PVR | 0.163 | < 0.001 | 0.202 | < 0.001 | 0.205 | < 0.001 |
| Cardiac index | − 0.085 | 0.035 | − 0.304 | < 0.001 | − 0.333 | < 0.001 |
| SVI | − 0.105 | 0.009 | − 0.341 | < 0.001 | − 0.355 | < 0.001 |
| SVO2 | − 0.134 | 0.001 | − 0.324 | < 0.001 | − 0.302 | < 0.001 |
ABG, admission blood glucose; HbA1c, hemoglobin A1c; mPAP, mean pulmonary arterial pressure; ln, logarithmically transformed; NT-proBNP, N-terminal pro-brain natriuretic peptide; PAH, pulmonary arterial hypertension; PVR, pulmonary vascular resistance; RAP, right atrial pressure; 6MWD, 6-min walk distance; SHR, stress hyperglycemia ratio; SVO2, mixed venous oxygen saturation; SVI, stroke volume index; WHO-FC, World Health Organization functional class